Lead author of Cochrane HPV review did not breach conflicts policy, find arbitersBMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4352 (Published 16 October 2018) Cite this as: BMJ 2018;363:k4352
- Nigel Hawkes
Cochrane has determined that the lead author of its review on human papillomavirus vaccine, Marc Arbyn, did not breach its rules on commercial sponsorship by not declaring his involvement in two organisations funded in whole or part by industry.
The complaints about alleged conflicts of interest undisclosed by Arbyn, of the Belgian Cancer Centre in Brussels, were made by several organisations and individuals after the review was published in May 2018.1 The first complaint seems to have come from the Japanese organisation Yakugai, which published a critique of the review on 7 June.2
Yakugai has campaigned against use of the vaccine, holding meetings at which people claiming to have been injured by the vaccine …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.